Pub Date : 2021-11-01DOI: 10.1136/gutjnl-2021-bsg.44
Luke D. Tyson, Professor Mark Thursz, E. Forrest, M. Allison, N. Vergis, S. Atkinson
{"title":"ATU-7 Incident acute kidney injury has a worse prognosis than baseline in severe alcoholic hepatitis","authors":"Luke D. Tyson, Professor Mark Thursz, E. Forrest, M. Allison, N. Vergis, S. Atkinson","doi":"10.1136/gutjnl-2021-bsg.44","DOIUrl":"https://doi.org/10.1136/gutjnl-2021-bsg.44","url":null,"abstract":"","PeriodicalId":112484,"journal":{"name":"Abstracts of distinction","volume":"10 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130493217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-11-01DOI: 10.1136/gutjnl-2021-bsg.41
C. Lamb, S. Sebastian, A. Kent, Jonathan P. Segal, H. Gonzalez, M. Brookes, S. Mehta, S. Subramanian, N. Bhala, L. Hicks, T. Conley, K. Patel, G. Walker, N. Kennedy
ATU-3 Frigure 1ConclusionsOur data provide reassurance for the continued evidence-based use of corticosteroids, immunomodulators and biologic therapies in IBD during the ongoing COVID-19 pandemic, and is consistent with an as yet unexplained association between mesalazine use and severe COVID-19 outcomes.
{"title":"ATU-3 Risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications: Reassuring insights from PREPARE-IBD","authors":"C. Lamb, S. Sebastian, A. Kent, Jonathan P. Segal, H. Gonzalez, M. Brookes, S. Mehta, S. Subramanian, N. Bhala, L. Hicks, T. Conley, K. Patel, G. Walker, N. Kennedy","doi":"10.1136/gutjnl-2021-bsg.41","DOIUrl":"https://doi.org/10.1136/gutjnl-2021-bsg.41","url":null,"abstract":"ATU-3 Frigure 1ConclusionsOur data provide reassurance for the continued evidence-based use of corticosteroids, immunomodulators and biologic therapies in IBD during the ongoing COVID-19 pandemic, and is consistent with an as yet unexplained association between mesalazine use and severe COVID-19 outcomes.","PeriodicalId":112484,"journal":{"name":"Abstracts of distinction","volume":"377 2","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114045298","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-11-01DOI: 10.1136/gutjnl-2021-bsg.40
J. Alexander, H. Ibraheim, Bhavisha P. Sheth, D. Pinato, J. Teare, A. Speight, S. Papa, A. Sharma, Shanthini M. Crusz, N. Powell
{"title":"ATU-2 A multi-centre study of Infliximab treatment for corticosteroid-refractory Checkpoint Inhibitor Induced enterocolitis","authors":"J. Alexander, H. Ibraheim, Bhavisha P. Sheth, D. Pinato, J. Teare, A. Speight, S. Papa, A. Sharma, Shanthini M. Crusz, N. Powell","doi":"10.1136/gutjnl-2021-bsg.40","DOIUrl":"https://doi.org/10.1136/gutjnl-2021-bsg.40","url":null,"abstract":"","PeriodicalId":112484,"journal":{"name":"Abstracts of distinction","volume":"257 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"113968953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-11-01DOI: 10.1136/gutjnl-2021-bsg.39
Pui Chi Lee, Umair Kamran, B. Coupland, W. Chapman, F. Varyani, Helan Steed, N. Trudgill
{"title":"ATU-8 Improved patient selection for PEG insertion in England between 2007–2019","authors":"Pui Chi Lee, Umair Kamran, B. Coupland, W. Chapman, F. Varyani, Helan Steed, N. Trudgill","doi":"10.1136/gutjnl-2021-bsg.39","DOIUrl":"https://doi.org/10.1136/gutjnl-2021-bsg.39","url":null,"abstract":"","PeriodicalId":112484,"journal":{"name":"Abstracts of distinction","volume":"3 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131446149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-11-01DOI: 10.1136/gutjnl-2021-bsg.46
D. King, B. Coupland, Anna Lock, V. Nanton, P. Patel, N. Trudgill
{"title":"ATU-5 Percutaneous liver biopsy to confirm advanced metastatic cancer: A step too far?","authors":"D. King, B. Coupland, Anna Lock, V. Nanton, P. Patel, N. Trudgill","doi":"10.1136/gutjnl-2021-bsg.46","DOIUrl":"https://doi.org/10.1136/gutjnl-2021-bsg.46","url":null,"abstract":"","PeriodicalId":112484,"journal":{"name":"Abstracts of distinction","volume":"7 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122023292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-11-01DOI: 10.1136/gutjnl-2021-bsg.45
A. J. Kuriakose Kuzhiyanjal, G. Nigam, G. Antoniou, R. Cross, F. Farraye, J. Limdi
{"title":"ATU-4 E-health versus standard care in inflammatory bowel disease management: A systematic review and meta-analysis","authors":"A. J. Kuriakose Kuzhiyanjal, G. Nigam, G. Antoniou, R. Cross, F. Farraye, J. Limdi","doi":"10.1136/gutjnl-2021-bsg.45","DOIUrl":"https://doi.org/10.1136/gutjnl-2021-bsg.45","url":null,"abstract":"","PeriodicalId":112484,"journal":{"name":"Abstracts of distinction","volume":"65 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134394625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：